|
Atypical Neuroleptics
Citations 31-40 of 262 total displayed.
|
Past content
(since Feb 1999):
|
- Special Section on Implications of CATIE
What CATIE Did: Some Thoughts on Implications Deep and Wide
- David Cunningham Owens
Psychiatr Serv 2008; 59: 530-533.
[Abstract]
[Full text]
[PDF]
- Special Section on Implications of CATIE
Impact of the CATIE Findings on State Mental Health Policy
- Joseph J. Parks, Alan Q. Radke, and Rajiv Tandon
Psychiatr Serv 2008; 59: 534-536.
[Abstract]
[Full text]
[PDF]
- Special Section on Implications of CATIE
NAMI Perspective on CATIE: Policy and Research Implications
- Kenneth Duckworth and Michael J. Fitzpatrick
Psychiatr Serv 2008; 59: 537-539.
[Abstract]
[Full text]
[PDF]
- Articles
Effect of Prior Authorization of Second-Generation Antipsychotic Agents on Pharmacy Utilization and Reimbursements
- Michael R. Law, Dennis Ross-Degnan, and Stephen B. Soumerai
Psychiatr Serv 2008; 59: 540-546.
[Abstract]
[Full text]
[PDF]
- Articles
Utilization and Costs of Antipsychotic Agents: A Canadian Population-Based Study, 1996–2006
- Silvia Alessi-Severini, Robert G. Biscontri, David M. Collins, Anita Kozyrskyj, Jitender Sareen, and Murray W. Enns
Psychiatr Serv 2008; 59: 547-553.
[Abstract]
[Full text]
[PDF]
- Articles
Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005
- Luuk J. Kalverdijk, Hilde Tobi, Paul B. van den Berg, Janelle Buiskool, Leonie Wagenaar, Ruud B. Minderaa, and Lolkje T. W. de Jong-van den Berg
Psychiatr Serv 2008; 59: 554-560.
[Abstract]
[Full text]
[PDF]
- Brief Reports
Brief Reports: Psychiatric Opinion and Antipsychotic Selection in the Management of Schizophrenia
- Melissa R. Arbuckle, Marc J. Gameroff, Steven C. Marcus, Joyce C. West, Joshua Wilk, and Mark Olfson
Psychiatr Serv 2008; 59: 561-565.
[Abstract]
[Full text]
[PDF]
- Brief Reports
Commentary: The Need to Guard Against Pharmaceutical Industry Influence
- Robert H. Howland
Psychiatr Serv 2008; 59: 566.
[Full text]
[PDF]
- Brief Reports
Antipsychotic Use in the Treatment of Outpatients With Schizophrenia in the VA From Fiscal Years 1999 to 2006
- Michael J. Sernyak and Robert A. Rosenheck
Psychiatr Serv 2008; 59: 567-569.
[Abstract]
[Full text]
[PDF]
- Columns
Datapoints: Second-Generation Antipsychotic Medication Combinations for Schizophrenia
- Carol Eisen, Roderick Shaner, Jürgen Unützer, Arlene Fink, and Kenneth B. Wells
Psychiatr Serv 2008; 59: 235.
[Full text]
[PDF]
|
|
